JPRN-jRCT2080220800未知3 期
ONO-7847 Phase 3 Study, A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7847 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Patients with Malignant Tumor.
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 344 人开始时间: 2009年8月10日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 344
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patients with malignant tumor who are to be intravenously administered cisplatin as a single dose of 70mg/m2 or higher within 3 hours
- •2.Patients whose performance status is 0 to 2
排除标准
- •1.In case of patients previously treated with cisplatin, those having no past history of vomiting as of administration of cisplatin
研究者
相似试验
未知
3 期
ONO-7436 Phase 3 StudyJPRN-jRCT2080220825ONO PHARMACEUTICAL CO.,LTD.22
招募中
3 期
ONO-2017-01:Phase III study of ONO-2017 in Japanese epileptic patients with generalized tonic-clonic seizure.Generalized tonic clonic seizures in adult patients with epilepsyJPRN-jRCT2031210624Osawa Masahiro12
未知
2 期
ONO-2745 IIb/III StudyPatients undergoing surgery requiring general anesthesiaJPRN-jRCT2080221928ONO PHARMACEUTICAL CO.,LTD.325
未知
2 期
ONO-2745 Phase II StudyPostoperative patients requiring sedation during artificial ventilation in intensive care unit.JPRN-jRCT2080221927ONO PHARMACEUTICAL CO.,LTD.90
进行中（未招募）
1 期
Randomised, Multicenter Phase III Clinical Study OfNanoplatin Plus Pemetrexed Versus Cisplatin Plus Pemetrexed As First Line Treatment In Inoperable (Stage III/IV) Non-Small Cell Lung Cancer Of Non-Squamous TypePatients with Inoperable (Stage III/IV) Non-Small Cell Lung Cancer Of Non-Squamous Type not previously treated with chemotherapy related to the current diseaseEUCTR2011-003612-24-GRRegulon AE884